Beilstein J. Org. Chem.2020,16, 1947–1954, doi:10.3762/bjoc.16.161
observed in the case of 6-trifluoromethyl-2-thiouracil that afforded 2- and 3-phosphonylated 5-oxothiazolopyrimidines in a 1:1 ratio.
Keywords: chloroethynylphosphonate; heterocyclization; phosphonylated thiazolopyrimidines; phosphonylation; thiazolopyrimidine; 2-thiouracil; Introduction
thiazolopyrimidine-5-ones by reacting 6-methyl-2-thiouracils with bromoethynylketones has been reported by Shishkin and co-workers (Scheme 4) [20]. The authors for the first time proved the structure of the 5-oxo isomer by single crystal X-ray diffraction analysis.
The Pd-catalyzed Sonogashira coupling reaction
. As the second reaction component, available 2-thiouracils were chosen as the most studied objects used for creating thiazolopyrimidine systems. The main objective of the study was to determine the regioselectivity of the reaction. Literature data mainly report the formation of 5-oxopyrimidines by
PDF
Graphical Abstract
Figure 1:
Structure of ritanserin and setoperone drugs.
Beilstein J. Org. Chem.2011,7, 1294–1298, doi:10.3762/bjoc.7.150
are used as common intermediates for post-condensation modifications such as cycloaddition, Liebeskind–Srogl reaction and Suzuki coupling to form biaryl-substituted dihydropyrimidinone, dihydropyrimidine, and thiazolopyrimidine compounds. The high efficiency of the diversity-oriented synthesis is
diversity-oriented synthesis of biaryl-substituted dihydropyrimidinone 5, thiazolopyrimidine 6, and dihydropyrimidine 7 compounds (Scheme 1). The perfluorooctanesulfonyl-attached benzaldehydes 1 were used as a key component for the Biginelli reactions [6]. The Biginelli products 4 were used as a common
effort was to convert them to thiazolopyrimidine through cyclocondensation with chloroacetone [16][17]. The reaction was performed in water under microwave heating at 120 °C for 30 min to afford thiazolopyrimidines 8a and 8b in 89% and 85% yields, respectively, after F-SPE. Suzuki reactions of 8a and 8b
PDF
Graphical Abstract
Scheme 1:
Synthesis of diverse dihydropyrimidine-related compounds.